Predict your next investment

Diversified Financial Services
cedarpointcapital.com

See what CB Insights has to offer

Investments

13

Portfolio Exits

1

About Cedar Point Capital

Cedar Point Capital offers diversified financial services.

Cedar Point Capital Headquarter Location

7300 Metro Blvd Suite 360

Minneapolis, Minnesota, 55439,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Cedar Point Capital News

Aria CV Raises $31M in Series B Funding

Feb 25, 2020

Aria CV, Inc., a St. Paul, Minn.-based developer of medical devices treating Pulmonary Arterial Hypertension (PAH), completed a $31m Series B round of financing. The round was led by Xeraya Capital, with participation from Longview Ventures, Catalyst Health Ventures, BioStar Ventures, Cedar Point Capital, Frontcourt Group, and three strategic investors. As part of this financing, Jason Rushton will join Darshana Zaveri (Catalyst Health Ventures), Maria Berkman (Longview Ventures), Renee Masi (BioStar Ventures) and Dan Gladney, on the Board of Directors. The company intends to use the funds to conduct the first clinical study in the United States designed to evaluate long term implants of the Aria CV Pulmonary Hypertension System (Aria CV PH System) in PAH patients. The round was closed one week after the Aria CV PH System was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA), which is intended to expedite the FDA review and approval of designated devices that may provide more effective treatment of life-threatening diseases. Founded in 2010 by Drs. John Scandurra and Karl Vollmers, following development work the two had done at the University of Minnesota’s Earl E. Bakken Medical Devices Center, and led by Dan Gladney, CEO and President, Aria CV has performed an acute first in human clinical study in Vienna, Austria and is now preparing for the U.S. clinical trial under the FDA’s Early Feasibility Study Program to evaluate long term implants in PAH patients. FinSMEs 25/02/2020

Cedar Point Capital Investments

13 Investments

Cedar Point Capital has made 13 investments. Their latest investment was in Aria CV as part of their Series B on January 1, 2020.

CBI Logo

Cedar Point Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/21/2020

Series B

Aria CV

$31M

No

3

12/7/2015

Growth Equity

Medicom Health

$3M

Yes

2

7/24/2015

Series A

Aria CV

$7.8M

Yes

1

6/28/2013

Unattributed - V

Subscribe to see more

$99M

Subscribe to see more

10

4/10/2013

Series E

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/21/2020

12/7/2015

7/24/2015

6/28/2013

4/10/2013

Round

Series B

Growth Equity

Series A

Unattributed - V

Series E

Company

Aria CV

Medicom Health

Aria CV

Subscribe to see more

Subscribe to see more

Amount

$31M

$3M

$7.8M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

2

1

10

10

Cedar Point Capital Portfolio Exits

1 Portfolio Exit

Cedar Point Capital has 1 portfolio exit. Their latest portfolio exit was Tactile Medical on July 28, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/28/2016

IPO

$99M

Public

6

Date

7/28/2016

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

6

Cedar Point Capital Team

2 Team Members

Cedar Point Capital has 2 team members, including current President, Richard Nigon.

Name

Work History

Title

Status

Richard Nigon

President

Current

John Seaberg

Platinum Group, and NeoChord

Executive Vice President

Current

Name

Richard Nigon

John Seaberg

Work History

Platinum Group, and NeoChord

Title

President

Executive Vice President

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.